Levels of renal cell arrest biomarker (u[TIMP-2]*[IGFBP7]) and damage biomarkers (uKIM-1 and IL-18) were significantly higher in patients with AKI progression as compared to those without. The gene discussed is TIMP2; the disease is acute kidney injury.